-
1
-
-
0028296232
-
Measurement of functional residual capacity by sulfur hexafluoride in small-volume lungs during spontaneous breathing and mechanical ventilation
-
A. Schulze, P. Schaller, A. Topfer, and H. Kirpalani. Measurement of functional residual capacity by sulfur hexafluoride in small-volume lungs during spontaneous breathing and mechanical ventilation. Pediatr. Res. 35: 494-499 (1994).
-
(1994)
Pediatr. Res.
, vol.35
, pp. 494-499
-
-
Schulze, A.1
Schaller, P.2
Topfer, A.3
Kirpalani, H.4
-
2
-
-
0031770372
-
FRC measurement in intensive care patients. A definition of standards
-
H.J. Wauer, B.A. Lorenz, and W.J. Kox. FRC measurement in intensive care patients. A definition of standards. Anaesthesist 47: 844-855 (1998).
-
(1998)
Anaesthesist
, vol.47
, pp. 844-855
-
-
Wauer, H.J.1
Lorenz, B.A.2
Kox, W.J.3
-
3
-
-
1342288613
-
Functional residual capacity and respiratory mechanics as indicators of aeration and collapse in experimental lung injury
-
C. Rylander, M. Hogman, G. Perchiazzi, A. Magnusson, and G. Hedenstierna. Functional residual capacity and respiratory mechanics as indicators of aeration and collapse in experimental lung injury. Anesth Analg. 98: 782-789 (2004).
-
(2004)
Anesth Analg.
, vol.98
, pp. 782-789
-
-
Rylander, C.1
Hogman, M.2
Perchiazzi, G.3
Magnusson, A.4
Hedenstierna, G.5
-
4
-
-
0031747981
-
Assessment of functional residual capacity using nitrogen washout and plethysmographic techniques in infants with and without bronchopulmonary dysplasia
-
R.R. Wauer, T. Maurer, T. Nowotny, and G. Schmalisch. Assessment of functional residual capacity using nitrogen washout and plethysmographic techniques in infants with and without bronchopulmonary dysplasia. Intensive Care Med. 24: 469-475 (1998).
-
(1998)
Intensive Care Med.
, vol.24
, pp. 469-475
-
-
Wauer, R.R.1
Maurer, T.2
Nowotny, T.3
Schmalisch, G.4
-
5
-
-
0033771767
-
Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3-heptafluoropropane) following whole-body exposure
-
H.H. Emmen, E.M. Hoogendijk, W.A. Klopping-Ketelaars, H. Muijser, E. Duistermaat, J.C. Ravensberg, D.J. Alexander, D. Borkhataria, G.M. Rusch, and B. Schmit. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3- heptafluoropropane) following whole-body exposure. Regul. Toxicol. Pharmacol. 32: 22-35 (2000).
-
(2000)
Regul. Toxicol. Pharmacol.
, vol.32
, pp. 22-35
-
-
Emmen, H.H.1
Hoogendijk, E.M.2
Klopping-Ketelaars, W.A.3
Muijser, H.4
Duistermaat, E.5
Ravensberg, J.C.6
Alexander, D.J.7
Borkhataria, D.8
Rusch, G.M.9
Schmit, B.10
-
6
-
-
0029814958
-
Biotransformation of the aerosol propellant 1,1,1,2,3,3,3- heptafluoropropane (HFA-227): Lack of protein binding of the metabolite hexafluoroacetone
-
U. Koster, D. Mayer, H.M. Deger, and W. DeKant. Biotransformation of the aerosol propellant 1,1,1,2,3,3,3-heptafluoropropane (HFA-227): lack of protein binding of the metabolite hexafluoroacetone. Drug Metab. Dispos. 24: 906-910 (1996).
-
(1996)
Drug Metab. Dispos.
, vol.24
, pp. 906-910
-
-
Koster, U.1
Mayer, D.2
Deger, H.M.3
DeKant, W.4
-
7
-
-
0004835628
-
Human inhalation of Halon 1301, HFC 134a and HFC 227ea for collection of pharmacokinetic data
-
Occupational and Environmental Health Directorate, Toxicology Division, Armstrong Laboratory
-
A. Vinegar, G.W. Jepson, R. Cook, J.D. McCafferty, and M.C. Caracci. Human inhalation of Halon 1301, HFC 134a and HFC 227ea for collection of pharmacokinetic data. Occupational and Environmental Health Directorate, Toxicology Division, Armstrong Laboratory, Wright Patterson Air Force Base Report No. AL/OE-TR-1997-0116, 1997.
-
(1997)
Wright Patterson Air Force Base Report No. AL/OE-TR-1997-0116
-
-
Vinegar, A.1
Jepson, G.W.2
Cook, R.3
McCafferty, J.D.4
Caracci, M.C.5
|